Effect of SGLT2 Inhibitor on Blood Glucose Profile in Type 2 Diabetic Patients Using Basal Insulin
Condition: Type2 Diabetes Intervention: Drug: SGLT2 inhibitor Sponsor: Nanjing First Hospital, Nanjing Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials